ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 13317 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 13317; 2) Community: the network communities that were significantly associated with the response to NSC 13317; 3) Molecule: the relationships between components within communities and NSC 13317; 4) MDR: the compounds that were significantly associated with the NSC 13317.

NSC Compound Enrichment Correlation
NSC 348401 4-(6-Thioguanine)-7-nitro-2,1,3-benzoxadiazole 0.0312262198176283 0.30901848
NSC 53861 Null 0.0312262198176283 0.1492622
NSC 624358 Tricyclo[4.4.0.0(2,7)]decane-5-one, 4,4-dibromo-2-methyl- 0.0312262198176283 0.41712655
NSC 626159 Girolline 0.0312262198176283 -0.08795929
NSC 629749 .beta.-Lapachone 0.0312262198176283 0.16888437
NSC 634368 Chlorobis(4-ethyltropolonato)bismuth(III) 0.0312262198176283 0.24711946
NSC 635979 Null 0.0312262198176283 0.27218947
NSC 645892 Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- 0.0312262198176283 -0.13106577
NSC 648365 Insulin-Methotrexate conjugate 0.0312262198176283 0.46149736
NSC 658455 (S,S)(-)3,5-Dimethoxy N-(.alpha.-Phenethyl)phenyl isopropylamine 0.0312262198176283 0.58666438
Total:70  Current:48    [First] [Prev] [Next] [Last]